Pfizer Pill

• U.S. doctors reconsider use of Pfizer’s COVID-19 pill for lower-risk patients

  Paxlovid's emergency authorization stipulates that it should be used only for newly infected people with risk factors, but doctors said many others have sought out a prescription.

  Health

  May 28, 2022
  
• Isolate if you catch COVID again after taking Pfizer’s pill, U.S. CDC says

  Although Pfizer says such incidents are rare, the U.S. CDC advises reinfected COVID patients to isolate for five days even after treatment.

  Health

  May 25, 2022
  
• Advertisement
• Pfizer’s new COVID-19 drug is in Nova Scotia. How will it be used?

  Nova Scotians deemed most vulnerable and at highest risk will be contacted after testing positive if they qualify and are chosen to take the pill.

  Health

  Jan 25, 2022
• Advertisement
• Canadian officials hopeful COVID-19 treatments will help ease strain on hospitals

  A new study suggests the antiviral medication remdesivir could have a “modest but significant effect” on COVID-19 patient outcomes.

  Canada

  Jan 20, 2022
• Pfizer’s antiviral COVID-19 pill approved by U.K. regulators

  Pfizer this month said Paxlovid showed near 90 per cent efficacy in preventing hospitalizations and deaths in high-risk COVID-19 patients.

  World

  Dec 31, 2021
• Pfizer begins approval process for COVID-19 antiviral pill in Canada

  Pfizer Inc said on Wednesday it had started the real-time submission of its application seeking Health Canada's approval of its oral COVID-19 antiviral drug candidate.

  Canada

  Dec 1, 2021
• Pfizer to allow other companies to make its COVID-19 pill

  COVID-19 vaccine maker Pfizer has agreed to grant a license for its antiviral pill to the Medicines Patent Pool, which would allow other companies to make the treatment.

  Health

  Nov 16, 2021
• What are antiviral COVID-19 pills and how could they help?

  Public health experts have described the implementation of antiviral pills as potentially game-changing in the fight against the COVID-19 pandemic.

  Canada

  Nov 6, 2021
• Advertisement
• New Pfizer COVID-19 pill reduces hospital, death risk by 90%, company says

  Pfizer's pill to treat COVID-19 reduces the risk of hospitalization and death by nearly 90 per cent, the company said Friday when it released preliminary results.

  Health

  Nov 5, 2021